AssetMark Inc’s Crinetics Pharmaceuticals CRNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$537K Buy
18,667
+603
+3% +$17.3K ﹤0.01% 1034
2025
Q1
$606K Sell
18,064
-97
-0.5% -$3.25K ﹤0.01% 950
2024
Q4
$929K Buy
18,161
+1,014
+6% +$51.8K ﹤0.01% 865
2024
Q3
$876K Buy
17,147
+2,030
+13% +$104K ﹤0.01% 807
2024
Q2
$677K Buy
15,117
+4,331
+40% +$194K ﹤0.01% 831
2024
Q1
$505K Buy
+10,786
New +$505K ﹤0.01% 829